Neurodegenerative disorders with extensive tau pathology: a comparative study and review - PubMed (original) (raw)

Review

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

M B Feany et al. Ann Neurol. 1996 Aug.

Abstract

Many neurodegenerative disorders with onset in mid to late adult life present diagnostic challenges to clinicians and pathologists alike. A distinguishing neuropathological feature has traditionally been the presence or absence of neurofibrillary tangles. Recent biochemical and molecular biological studies have identified the microtubule-binding protein tau as the predominant component of these and related inclusions, and have provided powerful new reagents for the study of neurodegenerative diseases. Several diseases previously considered distinct pathophysiological entities contain similar tau-immunoreactive lesions, but qualitative and regional anatomical differences in vulnerability can differentiate the disorders. Comparison of tau-immunoreactive lesions in three relatively uncommon neurodegenerative diseases-progressive supranuclear palsy, Pick's disease, and corticobasal degeneration-illustrates the types of analyses that demonstrate unexpected pathological similarities, but also fundamental differences between these disorders. These results have important implications for the differential diagnosis of disorders containing tau-immunoreactive lesions, including Alzheimer's disease.

PubMed Disclaimer

Cited by

Ligand electronic properties modulate tau filament binding site density.
Cisek K, Jensen JR, Honson NS, Schafer KN, Cooper GL, Kuret J. Cisek K, et al. Biophys Chem. 2012 Aug-Sep;170:25-33. doi: 10.1016/j.bpc.2012.09.001. Epub 2012 Sep 11. Biophys Chem. 2012. PMID: 23072817 Free PMC article.
Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.
Murakami T, Paitel E, Kawarabayashi T, Ikeda M, Chishti MA, Janus C, Matsubara E, Sasaki A, Kawarai T, Phinney AL, Harigaya Y, Horne P, Egashira N, Mishima K, Hanna A, Yang J, Iwasaki K, Takahashi M, Fujiwara M, Ishiguro K, Bergeron C, Carlson GA, Abe K, Westaway D, St George-Hyslop P, Shoji M. Murakami T, et al. Am J Pathol. 2006 Oct;169(4):1365-75. doi: 10.2353/ajpath.2006.051250. Am J Pathol. 2006. PMID: 17003492 Free PMC article.
Signature tau neuropathology in gray and white matter of corticobasal degeneration.
Forman MS, Zhukareva V, Bergeron C, Chin SS, Grossman M, Clark C, Lee VM, Trojanowski JQ. Forman MS, et al. Am J Pathol. 2002 Jun;160(6):2045-53. doi: 10.1016/S0002-9440(10)61154-6. Am J Pathol. 2002. PMID: 12057909 Free PMC article.
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Santacruz K, Smith CD, Patel E, Markesbery WR. Nelson PT, et al. J Neuropathol Exp Neurol. 2009 Jul;68(7):774-84. doi: 10.1097/NEN.0b013e3181aacbe9. J Neuropathol Exp Neurol. 2009. PMID: 19535994 Free PMC article.
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.
Reynolds MR, Reyes JF, Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI. Reynolds MR, et al. J Neurosci. 2006 Oct 18;26(42):10636-45. doi: 10.1523/JNEUROSCI.2143-06.2006. J Neurosci. 2006. PMID: 17050703 Free PMC article.

Neurodegenerative disorders with extensive tau pathology: a comparative study and review - PubMed (original) (raw)